Relatively low levels of NO that selectively enhance the formation of cGMP by sGC, if it is expressed, and other agents that enhance the levels of cGMP suppress the CSL cell phenotype in general and thus are expected to suppress tumor growth, metastasis, and recurrence. The gene discussed is SGCB; the disease is neoplasm.